# Akarna Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/akarna-therapeutics

- Industry: Pharmaceuticals
- Headquarters: Cambridge, UK
- Website: www.akarna.com
- Total disclosed funding: $16M
- Latest round: Series B (Jan 5, 2016)
- Investors on record: 3

## About

Founded in 2014 and based in Cambridge, UK, Akarna Therapeutics Ltd. is a biopharmaceutical company that develops novel small molecule therapeutics that target inflammatory and fibrotic diseases.

## Funding rounds

- Series B, Jan 5, 2016, $15M — Forbion, Third Point, New Science Ventures
- Series A, Feb 9, 2015, $1.3M — Third Point, New Science Ventures

## Investors

- Third Point (https://capitalatlas.ai/funds/third-point) — Series A, Series B
- New Science Ventures (https://capitalatlas.ai/funds/new-science-ventures) — Series A, Series B
- Forbion (https://capitalatlas.ai/funds/forbion) — Series B